{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T08:58:18Z","timestamp":1791104298184,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gyn\u00e9cologie Obst\u00e9trique &amp; Fertilit\u00e9"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.gyobfe.2007.02.013","type":"journal-article","created":{"date-parts":[[2007,3,28]],"date-time":"2007-03-28T07:19:14Z","timestamp":1175066354000},"page":"388-397","source":"Crossref","is-referenced-by-count":10,"title":["Traitement hormonal chez\u00a0les\u00a0femmes m\u00e9nopaus\u00e9es: tous les\u00a0traitements sont-ils \u00e9quivalents?"],"prefix":"10.1016","volume":"35","author":[{"given":"C.","family":"Ribot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Tr\u00e9mollieres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gyobfe.2007.02.013_bib1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/jama.288.1.49","article-title":"Cardiovascular disease outcomes during 6,8\u00a0years of hormone therapy","volume":"288","author":"Grady","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.gyobfe.2007.02.013_bib2","first-page":"1701","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.gyobfe.2007.02.013_bib3","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(03)14065-2","article-title":"Breast cancer and hormone-replacement therapy in the Million Women Study","volume":"362","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.gyobfe.2007.02.013_bib4","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa030808","article-title":"Estrogen plus progestin and the risk of coronary heart disease","volume":"349","author":"Manson","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.gyobfe.2007.02.013_bib5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1089\/jwh.2006.15.35","article-title":"Hormone therapy and coronary heart disease: The role of time since menopause and age at hormone initiation","volume":"15","author":"Grodstein","year":"2006","journal-title":"J Womens's Health"},{"key":"10.1016\/j.gyobfe.2007.02.013_bib6","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","article-title":"Effects or conjugated equine estrogen in postmenopausal women with hysterectomy. The Women's Health Initiative randomized controlled trial","volume":"291","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.gyobfe.2007.02.013_bib7","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/ijc.20710","article-title":"Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort","volume":"114","author":"Fournier","year":"2005","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.gyobfe.2007.02.013_bib8","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/embo-reports\/kve185","article-title":"Estrogen receptors: orchestrators of pleiotropic responses","volume":"21","author":"Moggs","year":"2001","journal-title":"EMBO Rep."},{"key":"10.1016\/j.gyobfe.2007.02.013_bib9","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0378-4274(01)00503-3","article-title":"Tissue-specific estrogenic response and molecular mechanisms","volume":"127","author":"Diel","year":"2002","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.gyobfe.2007.02.013_bib10","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.1210\/jc.82.12.4258","article-title":"Human estrogen receptor \u00df: gene structure, chromosomal localization and expression pattern","volume":"82","author":"Ennmark","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.gyobfe.2007.02.013_bib11","first-page":"291","article-title":"The A and B isoforms of the human progesterone receptor: two functionnally different transcription factors encoded by a single gene","volume":"54","author":"Giangrande","year":"1999","journal-title":"Recent Prog. Horm. Res."},{"key":"10.1016\/j.gyobfe.2007.02.013_bib12","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1128\/MCB.20.9.3102-3115.2000","article-title":"The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactors binding","volume":"20","author":"Giangrande","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.gyobfe.2007.02.013_bib13","first-page":"1","article-title":"Estrogen receptors and selective estrogen receptor modulators: molecular and cellular pharmacology","volume":"96","author":"Nilsson","year":"2005","journal-title":"Basics Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.gyobfe.2007.02.013_bib14","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/0002-9378(87)90166-9","article-title":"Pharmacology and pharmacokinetics of estrogens","volume":"156","author":"Lieveretz","year":"1987","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.gyobfe.2007.02.013_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/carcin\/19.1.1","article-title":"Functionnal role of estrogen metabolism in target cells: review and perspectives","volume":"19","author":"Zhu","year":"1998","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.gyobfe.2007.02.013_bib16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/oxfordjournals.jncimonographs.a024248","article-title":"Tissue-specific synthesis and oxydative metabolism of estrogens","volume":"27","author":"Jefcoate","year":"2000","journal-title":"J. Natl. Cancer Inst. Monog."},{"key":"10.1016\/j.gyobfe.2007.02.013_bib17","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.canlet.2004.10.007","article-title":"Cytochrome P450-mediated metabolism of estrogens and its regulation in humans","volume":"227","author":"Tsuchiya","year":"2005","journal-title":"Cancer Lett."},{"key":"10.1016\/j.gyobfe.2007.02.013_bib18","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1210\/jc.86.5.2263","article-title":"Polymorphism of the aromatase gene in postmenopausal italian women: distribution and correlation with bone mass and fracture risk","volume":"86","author":"Masi","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.gyobfe.2007.02.013_bib19","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0960-0760(97)80004-0","article-title":"Endocrine disorders associated with high aromatase expression","volume":"61","author":"Bulun","year":"1997","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.gyobfe.2007.02.013_bib20","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1016\/j.ejca.2003.08.017","article-title":"Association of genetic polymorphisms in CPY19 and CPY1A1 with the estrogen-receptor positive breast cancer risk","volume":"39","author":"Miyoshi","year":"2003","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.gyobfe.2007.02.013_bib21","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.1210\/jc.2004-0331","article-title":"Specificty and selectivity of the conjugation of estradiol, estrone and their catecholestrogen and methoxyestrogen metabolites by human uridine diphospho-glucuronyltransferases expressed in endometrium","volume":"89","author":"Lepine","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.gyobfe.2007.02.013_bib22","doi-asserted-by":"crossref","first-page":"10937","DOI":"10.1073\/pnas.94.20.10937","article-title":"Molecular origin of cancer: catechol-estrogen, 3,4 quinones as endogenous tumor initiators","volume":"94","author":"Cavalieri","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.gyobfe.2007.02.013_bib23","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0960-0760(03)00377-7","article-title":"Genotoxic metabolites of estradiol in breast: potential mechanisms of estradiol induced carcinogenesis","volume":"86","author":"Yue","year":"2003","journal-title":"J. Ster. Biochem. Mol. Biol."},{"key":"10.1016\/j.gyobfe.2007.02.013_bib24","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tem.2004.05.007","article-title":"Genotoxicity of steroidal estrogens","volume":"15","author":"Russo","year":"2004","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.gyobfe.2007.02.013_bib25","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1196\/annals.1322.029","article-title":"A unifying mechanism in the initiation of cancer and other diseases by catechol-quinones","volume":"1028","author":"Cavalieri","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.gyobfe.2007.02.013_bib26","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1021\/tx0498657","article-title":"In vitro model of mammary estrogen metabolism: structural and kinetic differences between catechol estrogens 2- and 4- hydroxyestriol","volume":"17","author":"Dawling","year":"2004","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.gyobfe.2007.02.013_bib27","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.maturitas.2005.08.010","article-title":"Comparison of possible carcinogenic estradiol metabolites: effect on proliferation, apoptosis and metastasis of human breast cancer cells","volume":"54","author":"Seeger","year":"2006","journal-title":"Maturitas"},{"key":"10.1016\/j.gyobfe.2007.02.013_bib28","first-page":"936","article-title":"The 4-pregnene and 5\u03b1-progesterone metabolites formed in nontumorous and tumorous breast tissue have opposite effects on breast cell proliferation and adhesion","volume":"60","author":"Wiebe","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.gyobfe.2007.02.013_bib29","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1359\/jbmr.2000.15.12.2479","article-title":"The protective effect of hormone replacement therapy on fracture risk is modulated by estrogen alpha receptor genotype in early postmenopausal women","volume":"15","author":"Salmen","year":"2000","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.gyobfe.2007.02.013_bib30","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1210\/en.140.2.556","article-title":"Interactive quantitative trait loci control phenotypic variation in murine estradiol-regulated response","volume":"140","author":"Roper","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.gyobfe.2007.02.013_bib31","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1521-690X(02)00079-9","article-title":"Hormone therapy and venous thromboembolism","volume":"17","author":"Peverill","year":"2003","journal-title":"Best Practice Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.gyobfe.2007.02.013_bib32","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.282.7.637","article-title":"Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized trial","volume":"282","author":"Ettinger","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.gyobfe.2007.02.013_bib33","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1055\/s-0038-1649632","article-title":"Haemostatic variables and menopausal status: influence of hormone replacement therapy","volume":"70","author":"Scarabin","year":"1993","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.gyobfe.2007.02.013_bib34","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1161\/01.ATV.17.11.3071","article-title":"Effects of oral and transdermal estrogen\/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial","volume":"17","author":"Scarabin","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.gyobfe.2007.02.013_bib35","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/01.ATV.0000087141.05044.1F","article-title":"Differential effects of oral and transdermal estrogen\/progesterone regimens on sensitivity to activated protein C among postmenopausal women: a randomized trial","volume":"23","author":"Oger","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.gyobfe.2007.02.013_bib36","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(03)14066-4","article-title":"Differential associations of oral and transdermal oestrogen replacement therapy with venous thromboembolism risk","volume":"362","author":"Scarabin","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.gyobfe.2007.02.013_bib37","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1530\/eje.0.1500113","article-title":"Estrogen and atherosclerosis","volume":"150","author":"Arnal","year":"2004","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.gyobfe.2007.02.013_bib38","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1055\/s-0037-1615643","article-title":"Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women","volume":"85","author":"Vehkavaara","year":"2001","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.gyobfe.2007.02.013_bib39","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1161\/01.CIR.0000032261.12632.D7","article-title":"Different effects of oral conjucated equine estrogen and transdermal estrogen replacement therapy on size and oxydative susceptibility of low-density lipoprotein particles in. postmenopausal women","volume":"106","author":"Wakatsuki","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.gyobfe.2007.02.013_bib40","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1210\/jc.2002-020891","article-title":"Differential effects of oral and transdermal estradiol treatment on circulating estradiol fatty acid ester concentrations in postmenopausal women","volume":"88","author":"Vihma","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.gyobfe.2007.02.013_bib41","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1161\/01.CIR.102.22.2687","article-title":"Differential effects of oral and transdermal estrogen replacement therapy on endothelial function in postmenopausal women","volume":"102","author":"Vehkavaara","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.gyobfe.2007.02.013_bib42","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1055\/s-0037-1613263","article-title":"Effects of transdermal and oral estrogen replacement therapy on C-reactive protein levels in post-menopausal women: a randomized, placebo-controlled trial","volume":"88","author":"Post","year":"2002","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.gyobfe.2007.02.013_bib43","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1161\/01.ATV.0000074146.36646.C8","article-title":"Effect of oral and transdermal estrogen replacement therapy on hemostatic variables associated with venous thrombosis: a randomized, placebo-controlled study in postmenopausal women","volume":"23","author":"Post","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.gyobfe.2007.02.013_bib44","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/01.ATV.0000087141.05044.1F","article-title":"SARAH investigators. Differential effects of oral and transdermal estrogen\/progesterone regimens on sensitivity of activated protein C among postmenopausal women: a randomized trial","volume":"23","author":"Oger","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.gyobfe.2007.02.013_bib45","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0015-0282(02)04661-7","article-title":"A randomized-placebo-controlled study of the effect of transdermal vs oral estradiol with or without gestodene on homocysteine levels","volume":"79","author":"Smolders","year":"2003","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.gyobfe.2007.02.013_bib46","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1055\/s-0037-1616563","article-title":"Different effects of low-dose transdermal and oral estrogen replacement therapy on pro-carboxy-peptidase U, an inhibitor of fibrinolysis in healthy post-menopausal women: a randomized, placebo-controlled study","volume":"93","author":"Post","year":"2005","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.gyobfe.2007.02.013_bib47","first-page":"27","article-title":"Less effects of intra-nasal than oral hormone therapy on factors associated with venous thrombosis risk in healthy postmenopausal women","author":"Post","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.gyobfe.2007.02.013_bib48","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1210\/jc.2005-2789","article-title":"Effects of hormone replacement therapy type and route of administration on plasma matrix metalloproteinases and their tissue inhibitors in postmenopausal women","volume":"91","author":"Lewandowski","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.gyobfe.2007.02.013_bib49","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/humrep\/del034","article-title":"No increase in C-reactive protein during intra nasal compared to oral hormone therapy in healthy postmenopausal women","volume":"21","author":"Hemelaar","year":"2006","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.gyobfe.2007.02.013_bib50","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.atherosclerosis.2005.12.030","article-title":"Different effects of oral conjugated estrogen and transdermal estradiol on arterial stiffness ans vascular inflammatory markers in postmenopausal women","volume":"189","author":"Sumino","year":"2006","journal-title":"Atheroclerosis"},{"key":"10.1016\/j.gyobfe.2007.02.013_bib51","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM198908033210505","article-title":"The risk of breast cancer after estrogen and estrogen-progestin replacement","volume":"321","author":"Bergkvist","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.gyobfe.2007.02.013_bib52","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0039-128X(03)00138-7","article-title":"Risk of breast cancer with progestins: critical assessment of current data","volume":"68","author":"Santen","year":"2003","journal-title":"Steroids"},{"key":"10.1016\/j.gyobfe.2007.02.013_bib53","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/(SICI)1097-0215(19990505)81:3<339::AID-IJC5>3.0.CO;2-6","article-title":"Breast-cancer risk following long-term oestrogen and oestrogen-progestin-replacement therapy","volume":"81","author":"Magnusson","year":"1999","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.gyobfe.2007.02.013_bib54","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.maturitas.2006.07.003","article-title":"Differential effects of progestogens, by type and regimen, on estrogen-metabolizing enzymes in human brest cancer cells","volume":"56","author":"Xu","year":"2007","journal-title":"Maturitas"},{"key":"10.1016\/j.gyobfe.2007.02.013_bib55","doi-asserted-by":"crossref","DOI":"10.1097\/01.gme.0000247017.41007.80","article-title":"Effects of estradiol with micronized progesterone or medroxyprogesterone acetate on risk markers for breast cancer in postmenopausal monkeys","author":"Wood","year":"2007","journal-title":"Menopause"},{"key":"10.1016\/j.gyobfe.2007.02.013_bib56","doi-asserted-by":"crossref","first-page":"10506","DOI":"10.1073\/pnas.1334098100","article-title":"Divergent impact of progesterone and medroxxprogesterone acetate on nuclear mitogen activated protein kinase signaling","volume":"100","author":"Nilsen","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.gyobfe.2007.02.013_bib57","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1001\/jama.287.2.216","article-title":"Serum estradiol level and risk of breast cancer during treatment with raloxifene","volume":"287","author":"Cummings","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.gyobfe.2007.02.013_bib58","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1001\/jama.295.14.1647","article-title":"Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy","volume":"295","author":"Stefanick","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.gyobfe.2007.02.013_bib59","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1021\/tx980217v","article-title":"The major metabolite of equilin, 4-hydroxyequilin autoxidizes to an o-quinone which isomerizes to the potent cytotoxin 4-hydroxyequilenin-o-quinone","volume":"12","author":"Zhang","year":"1999","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.gyobfe.2007.02.013_bib60","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.mrfmmm.2004.02.005","article-title":"Equine estrogen metabolite 4-hydroxyequilenin induces anchorage-independent growth of human mammary epithelial MCF-10A: differential gene expression","volume":"55","author":"Cuendet","year":"2004","journal-title":"Mutat. Res."},{"key":"10.1016\/j.gyobfe.2007.02.013_bib61","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/cmt.6.3.221.227","article-title":"Comparison of the proliferative effects of estradiol and conjugated equine estrogens on human breast cancer cells and impact of continuous combined progestogen addition","volume":"6","author":"Mueck","year":"2003","journal-title":"Climacteric"},{"key":"10.1016\/j.gyobfe.2007.02.013_bib62","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0015-0282(98)00042-9","article-title":"Estradiol and progesterone regulate the proliferation of human breast epithelial cells","volume":"69","author":"Foidart","year":"1998","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.gyobfe.2007.02.013_bib63","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/jnci\/92.4.328","article-title":"Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin","volume":"92","author":"Ross","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.gyobfe.2007.02.013_bib64","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1023\/A:1020617415381","article-title":"Estrogen-progestin replacement therapy and breast cancer risk: the Women's Health Study (United States)","volume":"13","author":"Porch","year":"2002","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.gyobfe.2007.02.013_bib65","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/S0029-7844(02)02502-4","article-title":"Hormone replacement therapy regimens and breast cancer risk","volume":"100","author":"Weiss","year":"2002","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.gyobfe.2007.02.013_bib66","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/cncr.11205","article-title":"Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden","volume":"97","author":"Olsson","year":"2003","journal-title":"Cancer"}],"container-title":["Gyn\u00e9cologie Obst\u00e9trique &amp; Fertilit\u00e9"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297958907000860?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297958907000860?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T23:13:48Z","timestamp":1587424428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297958907000860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":66,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S1297958907000860"],"URL":"https:\/\/doi.org\/10.1016\/j.gyobfe.2007.02.013","relation":{},"ISSN":["1297-9589"],"issn-type":[{"value":"1297-9589","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}